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of overtesting and overdiagnosis (OverTD) is vital for reducing the burden of OverTD. Studies from
disparate contexts, disciplines and focusing on disparate healthcare issues have examined patient and
public understanding of OverTD. A synthesis is needed to bring this literature together, examine common
themes, strengthen conclusions and identify gaps. This will help steer further research, policy and
practice to improve patient and public understanding of OverTD. The objective of this study is to
synthesise qualitative research data about patient and public understanding of OverTD. METHODS AND
ANALYSIS: A thematic meta-synthesis will be used to synthesise primary qualitative research and
qualitative components of primary mixed-methods research about patient and public understanding of
OverTD. Studies published in English will be included. These will be identified using systematic searches
from inception to March 2020 in the Scopus, CINAHL, PsycINFO and MEDLINE databases. Studies that
satisfy eligibility criteria will be assessed for methodological quality using the Critical Appraisal Skills
Programme (CASP) checklist. Thematic meta-synthesis will comprise three stages: (1) line-by-line coding;
(2) generation of descriptive themes and (3) generation of analytic themes. Confidence in the synthesis
findings will be assessed using the Grading of Recommendations Assessment, Development and
Evaluation Confidence in Evidence (GRADE CERQual) approach. A summary of GRADE CERQual results
will be presented alongside the key themes. Study eligibility screening, data extraction, analysis and the
CASP and GRADE CERQual assessments will be undertaken independently by two review authors. ETHICS
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Abstract
Introduction Examining patient and public understanding
of overtesting and overdiagnosis (OverTD) is vital for
reducing the burden of OverTD. Studies from disparate
contexts, disciplines and focusing on disparate healthcare
issues have examined patient and public understanding
of OverTD. A synthesis is needed to bring this literature
together, examine common themes, strengthen
conclusions and identify gaps. This will help steer further
research, policy and practice to improve patient and public
understanding of OverTD. The objective of this study is
to synthesise qualitative research data about patient and
public understanding of OverTD.
Methods and analysis A thematic meta-synthesis
will be used to synthesise primary qualitative research
and qualitative components of primary mixed-methods
research about patient and public understanding of
OverTD. Studies published in English will be included.
These will be identified using systematic searches from
inception to March 2020 in the Scopus, CINAHL, PsycINFO
and MEDLINE databases. Studies that satisfy eligibility
criteria will be assessed for methodological quality using
the Critical Appraisal Skills Programme (CASP) checklist.
Thematic meta-synthesis will comprise three stages: (1)
line-by-line coding; (2) generation of descriptive themes
and (3) generation of analytic themes. Confidence in the
synthesis findings will be assessed using the Grading
of Recommendations Assessment, Development and
Evaluation Confidence in Evidence (GRADE CERQual)
approach. A summary of GRADE CERQual results will
be presented alongside the key themes. Study eligibility
screening, data extraction, analysis and the CASP
and GRADE CERQual assessments will be undertaken
independently by two review authors.
Ethics and dissemination Ethics approval is not required
for this secondary analysis of published data. The results
will be disseminated in peer-reviewed journals and may be
presented in conference papers and elsewhere.
PROSPERO registration number CRD42020156838

Introduction
The high prevalence of overtesting, overdiagnosis and overtreatment across a range
of health conditions is a global challenge.1
Overtesting is when diagnostic tests that are

Strengths and limitations of this study
►► The first meta-
synthesis of qualitative research

about patient and public understanding of overtesting and overdiagnosis.
►► Systematic search strategy informed by up-to-date
evidence about database and keyword optimisation.
►► Confidence in the qualitative meta-
synthesis
findings strengthened by use of the Grading of
Recommendations Assessment, Development and
Evaluation Confidence in Evidence approach.
►► Scope of the research limited by the exclusion of
studies not written in the English language and of
grey literature.

not indicated are used.2 It can lead to overdiagnosis,3 which is when a diagnosis is made
according to professional standards, but
when it is unlikely to benefit the patient.4
Overtesting and overdiagnosis (OverTD) can
lead to overtreatment,2 5 which is treatment
that does more harm than good.6
It is important to reduce overtesting, overdiagnosis and overtreatment.7 8 Overtesting can
lead to harms including unnecessary invasive procedures, false positives and misdiagnoses.2 Overdiagnosis can lead to unwanted
behavioural and psychological responses
in patients, such as reduced participation
in usual activities,9 stress and anxiety.10 11 A
diagnosis primes patients and physicians to
commence treatment, even for benign conditions.6 Overtreatment can lead to patient
suffering, treatment-
related complications,
loss of quality of life, lost productivity and
other burdens.6 12 Medical overuse is massively
costly to healthcare systems and to patients
and their families,2 13 14 and must be reduced
to maintain healthcare system sustainability.15
Improving patient and public understanding of OverTD is key to reducing
their incidence as well as the incidence of
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overtreatment.15 16 Both patients and the public need to be
aware of OverTD, as people regularly transition between
being in and out of medical care,17 and their medical
decision making is informed by beliefs that are formed
and reformed across contexts.18 Presently, patients and
the public often drive medical overuse. Some patients
and members of the public tend to over-rely on tests
and diagnoses,19 overestimating their benefits,20 21underestimating their risks22 as they cope with uncertainty
poorly.3 23 Few are aware that overtesting or overdiagnosis
occurs,24 25 and those who are often find the phenomena
difficult to understand.25 26 Research suggests that patient
outcomes would be improved if they understood OverTD
better.27 28 Patients with better knowledge about OverTD
make more appropriate screening and treatment decisions.25 Patient knowledge also influences the tests and
treatments prescribed by the medical practitioners,29 who
in some cases overuse medical interventions.30 31 Patients
and the public want to be informed about OverTD,21 and
need to understand both risks and benefits of medical
interventions in order to participate in shared decision
making.32
Research is increasingly examining patient and public
understanding of OverTD.33 Patient and public understandings of OverTD have been surveyed,24 34 and qualitatively examined, in relation to a range of conditions
and in multiple contexts.21 26–28 35 Researchers have
studied the challenges of communicating about OverTD
to the general public27 36 37 as well as to particular patient
groups, such as patients with low health literacy.38 Strategies are being developed to overcome these communication challenges. They include the development of
decision aids, which inform patients about the risks as
well as benefits of particular medical interventions,25 such
as breast cancer screening,39 and assist them in making
evidence-backed healthcare decisions.40 Other research
has focused on refining patient educational tools. This
includes studying how different concepts of OverTD resonate with patients and the public,41 the effects of information about overdiagnosis on patient screening decisions,21
and studying patients’ understandings of their own diagnoses.10 The use of mass media to reduce OverTD has
also been studied, such as how media narratives can influence cancer screening decisions42 43 or promote better
management of back pain.44
Despite progress in research, important gaps in
knowledge remain.16 45 46 First, existing studies are scattered across disciplines, contexts and focus on disparate
medical conditions.47 It is difficult to appraise the overall
state of research or glean its collective insights. Second,
while it is known that patients and the public find OverTD
unintuitive, little is known about why.15 48 A meta-synthesis
of qualitative data from research examining patient and
public understanding of OverTD will help address these
gaps. It will systematise insights from disparate disciplines,
contexts and topic areas by identifying descriptive themes
in the body of literature. The synthesis will also identify
analytic themes about the reasons for poor public and
2

patient understanding of OverTD. These findings will
inform future research by highlighting priority areas for
further enquiry. An increased understanding about why
patients and the public struggle to understand OverTD
may inform the development of educational interventions and other practice to improve their understanding.

Objective
The objective of this study is to synthesise data from qualitative research on patient and public understanding of
OverTD.

Methods
Thematic meta-synthesis will be used to examine primary
qualitative research and qualitative components of
mixed-methods research about patient and public understanding of OverTD.
The protocol is presented in accordance with the
Preferred Reporting Items for Systematic review and
Analysis Protocols (PRISMA-
P) checklist49 (availMeta-
able in online supplementary appendix 1).
Study selection criteria
Study selection criteria and their rationale are described
in table 1.
Search methods
The search process will comprise first an informal scoping
stage to develop search strategies, and then a formal main
stage to identify and collate eligible studies. The main
stage will identify English language studies indexed in
four databases from inception until March 2020.
The scoping stage will be exploratory. Its aims are to
become familiar with the literature, refine search parameters, identify MeSH terms and keywords and test the
preliminary search strategy.
The main stage will comprise the formal literature
search. It will be informed by the scoping stage, by search
strategy guidelines from the Cochrane Collaboration,50 51
guidelines for optimising database searches for medical
qualitative research52 and guidelines for searching the
individual databases used, such as for MEDLINE53 and
PsycINFO.54 Search filters will be identified for each of
the inclusion criteria. A subject librarian will contribute
to the development of the search strategy.
The following databases will be used: Scopus, CINAHL,
MEDLINE and PsycINFO. These were chosen because
they are most likely to index studies about patient
and public understanding of OverTD: social research
(Scopus); medicine/public health/health communication research (MEDLINE, CINAHL); psychological
research (PsycINFO) and generalist fields (Scopus). Database selection was also informed by research showing that
Scopus, MEDLINE and CINAHL searches retrieve some
of the largest numbers of qualitative health studies, and
the largest number of qualitative health studies not listed
Rozbroj T, et al. BMJ Open 2020;10:e037283. doi:10.1136/bmjopen-2020-037283
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Table 1 Study selection criteria
Inclusion criterion

Rationale

Primary, published, peer-reviewed
studies

Restricting the synthesis to primary, published, peer-reviewed studies matches the aims of
examining primary evidence.

Studies examining understanding

Understanding is defined as objectual understanding: understanding of something, such as
collection of ideas or a subject matter71. Studies examining participants’ knowledge, perceptions,
sentiments, values or experiential understanding will be included. This reflects that understanding
can be developed through experiential learning72, emotional learning73 as well as abstract learning.

Among patients and/or the public

The synthesis will examine understanding among both patients and the public. People regularly
transition between being one or the other17, and make diagnostic and screening decisions drawing
on understanding they developed overtime and in either role. So, it is appropriate to examine
understanding of OverTD among both groups.
It will be distinguished whether studies are about patients, the public or both. People have a differing
engagement with health decision making when they are patients or the public74. To account for
this, synthesis results for each group will be compared, and important intergroup differences will be
considered in study outcomes.

Of overtesting and/or overdiagnosis
(OverTD)

Studies about both overtesting (OT) and overdiagnosis (OD) will be included, as both are deeply
interlinked and underpinned by common broader patient ideas about healthcare. However,
understandings of OT and OD may differ. To account for this, studies will be classified based
on whether they examine OT, OD or both. The synthesis results will be compared by these
classifications, and important differences will be accounted for.
Synonymous concepts to overtesting and overdiagnosis will be included, such as ‘over-detection’
and ‘overuse of diagnostic testing’. The term ‘overdiagnosis’ was popularised relatively recently75,
but it was predated by earlier terms76, and it is important to capture these earlier studies.
Studies which did not explicitly aim to understand how to inform patients or the public about
OverTD are outside the scope of this synthesis and will be excluded. Studies that only address
overtreatment and not overtesting or overdiagnosis will also be excluded.

Either qualitative or mixed-methods
study design

Mixed-methods studies will be included where their qualitative components can still be examined in
the thematic meta-synthesis.
Quantitative components of mixed-methods studies will be excluded, as will studies where it is not
possible to differentiate between quantitative and qualitative components of analysis.

Published in the English language

Only English language studies will be included, as the authors are English speakers, and relying on
translations of non-English studies could introduce inaccuracies into the analysis.

Published in any year

There will be no date restrictions: older insights may still be relevant.

Conducted in any setting

There will be no setting restrictions: studies from all settings may potentially contain transferable
insights about patient and public understandings of OverTD.

Focusing on the general concepts
of OverTD and/or in relation to any
condition/s or interventions

While patient and public understanding of OverTD may differ depending on medical conditions,
there may be underlying themes across conditions, so it is relevant to include studies relating to any
conditions. The condition/s which a study focuses on will be noted. Study themes will be compared
by conditions in analysis if the sample characteristics make this viable.

by other databases.52Additionally, PsycINFO was included
despite indexing relatively few unique studies,52 because
it may index studies about psychosocial factors related to
understanding OverTD. Examples of all search strategies,
including filters for each criterion and Boolean operators, are included in online supplementary appendix 2.
Even where database selection is optimised, one study
shows that 7% of qualitative health studies that fit the
search parameters will not be retrieved, with the majority
not indexed by major databases.52 To increase the chances
of relevant studies being retrieved, the reference lists of
all studies included in the final sample will be scanned
for eligibility, and experts in the field will be contacted
to identify studies that may have been missed. Potentially eligible studies will be added to the data screening
process (described below).
The search may be rerun and results updated at a
future date if required (ie, after 12 months if study is not
yet published).
Rozbroj T, et al. BMJ Open 2020;10:e037283. doi:10.1136/bmjopen-2020-037283

Selection of studies
Study selection will comprise the following steps:
1. All study records identified using the search strategy
will be extracted with a PDF of the study manuscript
into EndNote reference management software.
2. Duplicate studies will be removed from the data.
3. Study titles and abstracts will be screened for eligibility
by two authors (TR and RH) working independently.
Eligible studies and studies where eligibility cannot be
clearly determined from the abstract and title will be
included for full-text review.
4. Full texts will be independently read and examined
for eligibility by TR and RH using a standardised
form. Ineligible studies will be screened out, and the
reason for exclusion recorded. Eligible studies will
be included in the analysis. Where the two authors
cannot agree on eligibility after discussion, a third author (DAO) will judge whether the study should be
included.
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5. The final sample of full text studies will be extracted to
NVivo research software.
The screening process will be reported in a PRISMA
diagram.55
Data extraction
The complete study manuscript will be extracted into
NVivo. Analysis will be undertaken on the Results sections
of manuscripts, including themes, subthemes and primary
data as reported in the manuscripts, such as participant
quotes. Primary data included in tables and sections of
manuscripts may also be analysed.
For each study, a standardised data collection form will
be completed to capture:
►► Study details: authors, year of publication, journal in
which study was published.
►► Research question/s.
►► Participants: sample size, demographic characteristics, whether they are patients and/or the public,
methods of participant recruitment and selection.
►► Setting: type/s of healthcare and/or conditions the
study focused on, whether the study examined overtesting and/or overdiagnosis, country where study
was completed, whether study was in urban or rural
settings.
►► Method of data collection (such as interview or
survey).
►► Method of data analysis (such as narrative analysis or
discourse analysis).
These details will be added as classifying information to
the extracted full text studies in NVivo.
Assessment of quality of included studies
The Critical Appraisal Skills Programme (CASP) qualitative checklist56 will be used to systematically examine
the reliability, validity and usefulness of individual studies
in the synthesis. The 10-item checklist comprises nine
fixed-response questions that can be answered: yes/can’t
tell/no (‘yes’ indicates a positive score), and one text-
response question. Two authors (TR and RH) will independently complete the CASP checklist for each study,
and any disagreements in scoring will be resolved by a
third author (DAO). A summary of CASP checklist results
will be reported as a table and interpreted in text.
Synthesis and analysis
A thematic meta-synthesis of the Results sections of manuscripts will be undertaken. Analysis will comprise three
main stages57: first, line-by-line coding; next, descriptive
thematic development, and finally; analytical theme
development.
The thematic meta-synthesis method was chosen for
several reasons. It fits the gaps this research responds to:
the descriptive phase will address the need to systematise
insights from disparate disciplines, contexts and topic
areas, while the analytical phase is an interpretive tool
with which synthesised studies can be re-
examined to
study why patients and the public find OverTD so difficult
4

to understand. Furthermore, thematic analysis is suitable for handling data from disparate contexts,58 which
fits this synthesis where included studies are likely to be
heterogeneous. Finally, thematic meta-synthesis is particularly suited to informing policy and practice,59 which
is an important consideration for this research. The
synthesis assumes an objective idealist epistemic position.
The synthesised studies are considered to convey something about reality, but this reality is conveyed through a
subjective lens.60 This is also assumed for the findings of
this synthesis.
The first stage of analysis will be line-by-line coding.
Authors will familiarise themselves with the data. TR will
inductively generate initial codes for ideas in the data,
coding over several iterations until no new codes are
needed to capture ideas. Single data fragments can be
assigned multiple codes. Once TR is satisfied with the code
frame, he will code the whole dataset, checking coding
for data coverage and refining it as necessary. A second
author (RH) will check a randomly selected sample of
10% of coded data for coding accuracy. A disagreement
score will be calculated, and disagreements discussed
and resolved, drawing on the wider team if required. An
agreement score of 85% or higher will be targeted.61 If
the agreement score is low, reasons for this will be investigated, and line-by-line coding may need to be repeated.
The second stage of analysis will be the development of
descriptive themes to organise existing ideas in the data.
TR and RH will independently organise individual codes
into broader themes. The two authors will then cooperate to develop one set of common descriptive themes,
discussing them with the wider author group. Themes
will be checked for data coverage and internal homogeneity.62 External heterogeneity will not be assessed, as
this is problematic where individual data can be multicoded. Themes will be revised until their fit with data is
optimised.
The third stage of analysis will be the development of
analytical themes capturing the barriers and enablers
to patient and public understanding of OverTD. This
stage will be interpretative and will seek to generate new
ideas.57 63 TR and RH will independently re-examine the
data organised into descriptive themes to infer what the
barriers and enablers to understanding OverTD are.64
This phase will rely on the authors’ subjectivities, and
the authors will take a reflexive approach to minimise
problems in interpretation and improve transparency
in analysis.65 TR and RH will meet to compare their
analytical themes. As part of researcher reflexivity, they
will discuss the factors that led to their interpretations,
including their assumptions, logical inferences and how
their interpretations may have been shaped by the predetermined research aims. Researcher reflexivity will also be
addressed in peer-reviewed publications resulting from
this research, including consideration about the ways in
which the authors’ own positions could have influenced
the study design, analysis and the interpretation of findings. TR and RH will determine the analytical themes,
Rozbroj T, et al. BMJ Open 2020;10:e037283. doi:10.1136/bmjopen-2020-037283
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which will be discussed and finalised with the wider
author group.
Descriptive and analytical thematic results will be
compared across a range of classifying variables, such
as whether data are from studies about patients/the
public/both, and whether data are from studies investigating understanding of overtesting/overdiagnosis/
both. Notable comparative differences will be reported
in the Results. Descriptive and analytical themes will be
tabulated and paired with exemplary data fragments. A
separate table will display how the data from each study is
represented in the coding.
Assessment of confidence in findings
The Grading of Recommendations Assessment, Development and Evaluation- Confidence in Evidence from
Reviews of Qualitative research (GRADE-
CERQual)
approach66 will be used to assess confidence in the
analytic synthesis results. GRADE-CERQual is used to
consider four factors about studies contributing to
review findings: (1) methodological limitations; (2) relevance; (3) adequacy of supporting data and (4) coherence. The overall confidence in each review finding
(ie, for each theme generated) will be graded as: high,
moderate, low or very low. GRADE-
CERQual assessments will be undertaken independently by two authors
(TR and RH). Any disagreements will be discussed until
consensus is achieved. Review findings, the confidence
judgement for each finding and an explanation of the
judgement will be presented in a Summary of Qualitative Findings table.
Assessment of methodological limitations
Methodological limitations in the synthesis will be judged
based on the aggregated CASP checklist results for all
included studies (described earlier).
Assessment of relevance
Relevance is ‘the extent to which the body of data from
the primary studies supporting a review finding is applicable to the context specified in the review question’
(Noyes et al, p53).67 Across synthesised studies contributing to each review finding, we will consider the years
of publication, settings in which studies were conducted,
target audiences and specificity of the findings. These will
determine how relevant the body of synthesised studies
is for developing knowledge about contemporary patient
and public understanding of OverTD in general.
Assessment of adequacy
Adequacy is the quantity and richness of data contributing
to a review finding.68 Quantity is defined as the number of
studies or data fragments supporting a theme. Richness is
defined as the extent to which themes are supported by
detailed, qualitative descriptions. Both parameters will be
considered to judge the adequacy of data for supporting
each theme in the synthesis results.
Rozbroj T, et al. BMJ Open 2020;10:e037283. doi:10.1136/bmjopen-2020-037283

Assessment of coherence
Coherence is ‘how clear and cogent the fit is between the
data from the primary studies and a review finding that
synthesises that data’ (Colvin et al, p35).69 To examine
coherence, the synthesis themes will be compared against
the results of individual synthesised studies, examining
the extent to which the synthesis findings align with individual study findings.
Patient and public involvement
A health consumer advocate from the Consumer’s Health
Forum of Australia was consulted in the development of
this protocol. They will advise on the interpretation of the
synthesis results.
Results
The Results will comprise two subsections:
1. The sample profile, describing classifying information
about the synthesised studies.
2. The thematic meta-synthesis results. Both descriptive
and analytical themes will be reported. The descriptive themes will form a minor part of the Results, summarised in a table and briefly interpreted in text. The
analytical themes will form a main part of the Results,
with all major analytical themes tabulated, described
in text and paired with exemplary data fragments and
GRADE-CERQual assessment findings.
The meta-synthesis will be reported in accordance with
the enhancing transparency in reporting the synthesis of
qualitative research statement.70
Ethics and dissemination
Ethics approval is not required for this secondary analysis of published data. The findings may be disseminated
in peer-
reviewed publications, conference papers and
elsewhere.
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